| 1. | Effective                Date. 24th                day of August, 2007 |
|----|------------------------------------------------------------------------|

| 2. | Scope                of Work. |
|----|-------------------------------|

| 3. | Principal                Investigator/Co-Investigator. |
|----|--------------------------------------------------------|

----

| 4. | Performance                Period. |
|----|------------------------------------|

| 5. | Records                and Reports. |
|----|-------------------------------------|

| 6. | Study                Material. |
|----|--------------------------------|

| 7. | Payment. |
|----|----------|

|   | A. | Sponsor                shall pay SHRI a sum of $350.00 per completed, evaluable subject,                who                completes the protocol and for whom a Case Report is submitted. The                sum                assumes enrollment up to 400 evaluable subjects in accordance with                the                scope of work set forth in the Protocol. The payment noted above                includes                all applicable overheads due any party or entity and shall be paid                on a                per patient basis. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | Payment                shall be made to SHRI according to Appendix B appended hereto and                incorporated by reference. All costs outlined in Appendix B shall                remain                firm for duration of the Research, unless otherwise agreed to in                writing                by SHRI and Sponsor. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | Checks                will be made payable to: “Sun Health Research Institute”, Tax ID No.                86-0768795 |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------|

----

|   | D. | The                payments shall be paid to SHRI within thirty (30) days after submission                of                subjects Case Reports by SHRI to Sponsor and the submission of an                accounting invoice. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8. | Confidential                Information. |
|----|------------------------------------------|
|   |   |
|--------|--------|

|   | A. | “Confidential                Information” as used herein shall mean compounds or substances and                information or data in written, oral or tangible form delivered by                or on                behalf of Sponsor hereunder for the performance of the Study and                which is                clearly labeled as confidential by Sponsor, or if presented in oral                form,                is immediately identified as confidential and is summarized and labeled                in                written form as confidential with fifteen (15) days of its oral                presentation. Confidential Information will not include any information                that: (i) was known by Sun Health Institute prior to its receipt                from                Sponsor; (ii) is generally publicly known or becomes publicly known                subsequent to its receipt from Sponsor through no fault of _Sun Health                Institute; (iii) is hereafter developed by Sun Health Institute                independent of any disclosure by Sponsor hereunder; or (iv) is received                by                Sun Health Institute from another party not under an obligation of                confidentiality to Sponsor. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | However,                Sun Health Institute agrees to retain Confidential Information in                such                confidence as Sun Health Institute retains its own confidential                information, not to reveal such Confidential Information to third                parties,                except, as required, to the Food and Drug Administration (FDA), without                the prior written permission of Sponsor, and to use such Confidential                Information only for the purpose of conducting the research or work                hereunder. At the termination of this agreement all Confidential                Information (including copies and unused substances) will be returned                to                Sponsor, except that Sun Health Institute may retain one copy of                such                Confidential Information for archival purposes                only. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | The                results of the Study shall be treated in confidence by Sun Health                Institute, except that Sun Health Institute retains the right to                publish                any and all of its Study results, subject to a prior thirty (30)                day                period of review by Sponsor. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | D. | Sponsor                shall have the right to use, copy and distribute as it sees fit any                of the                published results of the Study and to use and copy unpublished research                results, provided that Sponsor may not use the name of Sun Health                Institute and its Principal Investigator for any public or commercial                purpose, including advertising, promotional or sales literature or                product                labeling without the prior written consent of Sun Health                Institute. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9. | HIPAA                Compliance. |
|----|----------------------------------|

|   | A. | Sponsor                and Sun Health Institute agree to comply with the applicable provisions                of                the Administrative Simplification section of the Health Insurance                Portability and Accountability Act of 1996, as codified at 42 U.S.C.§                1320d through d-8 (“HIPAA”), and the requirements of any regulations                promulgated thereunder including without limitation the federal privacy                regulations as contained in 45 CFR Part 164 (the “Federal Privacy                Regulations”) and the federal security standards as contained in 45 CFR                Part 142 (the “Federal Security Regulations”). Sponsor and Sun Health                Institute agree not to use or further disclose any protected health                information, as defined in 42 U.S.C. § 1320d (collectively, the “Protected                Health Information”), concerning a patient other than as permitted by this                Agreement and the requirements of HIPAA or regulations promulgated                under                HIPAA including without limitation the Federal Privacy Regulations                and the                Federal Security Regulations. Sponsor and Sun Health Institute will                implement appropriate safeguards to prevent the use or disclosure                of a                patient’s Protected Health Information other than as provided for by this                Agreement. Sponsor and Sun Health Institute will promptly report                to the                other any use or disclosure of a patient’s Protected Health Information                not provided for by this Agreement or in violation of HIPAA, the                Federal                Privacy Regulations, or the Federal Security Regulations of which                Sponsor                or Sun Health Institute becomes aware. In the event Sponsor or Sun                Health                Institute, with the other’s approval, contracts with any agents to whom it                provides a patient’s Protected Health Information, it shall include                provisions in such agreements whereby it and agent agree to the same                restrictions and conditions that apply to it with respect to such                patient’s Protected Health Information. Sponsor and Sun Health Institute,                will make its internal practices, books, and records relating to                the use                and disclosure of a patient’s Protected Health Information available to                the Secretary of Health and Human Services to the extent required                for                determining compliance with the Federal Privacy Regulations and the                Federal Security Regulations. Notwithstanding the foregoing, no                attorney-client, accountant-client, or other legal privilege shall                be                deemed waived by Sponsor or Sun Health Institute by virtue of this                Section. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 10. | Publication. |
|-----|--------------|

|   | A. | Prior                to submission for publication of a manuscript describing the results                of                any aspect of the Study, Sun Health Institute shall send Sponsor                a copy of                the manuscript to be submitted, and shall allow Sponsor thirty (30)                days                from the date of mailing to review the manuscript. The purposes for                such                review are i) to provide the Sponsor with the opportunity to review                and                comment on the contents of the proposed publication, ii) to identify                any                Confidential Information belonging to the Sponsor to be deleted from                the                proposed publication; and iii) to allow Sponsor to determine whether                the                manuscript contains subject matter for which patent protection should                be                sought prior to publication of such manuscript. Should Sponsor believe                the                manuscript contains Confidential Information belonging to Sponsor                or that                the subject matter of the manuscript contains a patentable invention,                then                prior to the expiration of thirty (30) days from the mailing date                of such                manuscript to Sponsor by Sun Health Institute Sponsor shall give                written                notification of such determination to Sun Health                Institute. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | After                the expiration of thirty (30) days from the date of mailing such                manuscript by Sponsor, unless Sun Health Institute has received the                written notice specified above from Sponsor, Sun Health Institute                shall be                free to submit such manuscript for publication and to publish the                disclosed research results in any manner consistent with academic                standards. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | Upon                receipt of such written notice from Sponsor that the manuscript contains                a                patentable invention, Sun Health Institute will thereafter delay                submission of the manuscript for an additional period of up to sixty                (60)                days to permit preparation and filing of U.S. patent application                on the                subject matter to be disclosed in such manuscript. After expiration                of                such sixty (60) day period, or the filing of a patent application                on each                such invention, whichever shall occur first, Sun Health Institute                shall be                free to submit the manuscript and to publish the disclosed                results. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | D. | Upon                receipt of written notice from Sponsor that the manuscript contains                Confidential Information of Sponsor, Sun Health Institute shall review                the                manuscript and delete Confidential Information of                Sponsor. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11. | Patents. |
|-----|----------|

|   | A. | Sun                Health Institute shall promptly disclose in writing to Sponsor any                invention made by Sun Health Institute, its employees or the Principal                Investigator during the course of the performance of the Study and                with                respect to the Study drug/device. Sponsor shall maintain all such                disclosures in confidence and shall not deliver or divulge them to                any                person. Sun Health Institute hereby grants Sponsor a non-exclusive                royalty-free license to practice any such inventions and under any                patents                or patent applications which Sun Health Institute may file for such                inventions. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | Sponsor                shall also have an option to acquire an exclusive license to practice                any                such invention and patents and patent applications thereon upon reasonable                terms and conditions, including reasonable royalties, as the parties                may                mutually agree in a subsequent writing. The option granted in this                Section                10.B. shall commence on the date Sponsor receives a disclosure of                invention, as set forth in Section 10.A. and shall terminate one                hundred                eighty (180) days thereafter. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 12. | Indemnification. |
|-----|------------------|

| 13. | No                Assignment. |
|-----|-------------------------------|

| 14. | Use                of Name. |
|-----|-----------------------------|

|  | i) | in                any advertising, promotion or sales                literature; |
|--|----|----------------------------------------------------------------------------------|

|   | ii) | in                connection with any public or private offering or in conjunction                with any                application for regulatory approval, unless disclosure is otherwise                required by law, in which case Sponsor may make factual statements                concerning the Agreement or file copies of the Agreement after providing                Sun Health Institute with an opportunity to comment and reasonable                time                within which to do so on such issue pertaining to public announcements                about this Agreement or the status or existence of the Study without                prior                written approval of the other                party. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15. | Termination. |
|-----|--------------|

|   | A. | This                Agreement shall become effective upon the date first hereinabove                written                and shall continue in effect for the full duration of the Performance                Period unless sooner terminated. The parties hereto may, however,                extend                the term of this Agreement for additional periods as desired under                mutually agreeable terms and conditions which the parties reduce                to                writing and sign. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | In                the event that either party hereto shall commit any breach or default                in                any of the terms or conditions of this Agreement, and also shall                fail to                remedy such default or breach within thirty (30) days after receipt                of                written notice thereof from the other party hereto, the party giving                notice may, at its option and in addition to any other remedies which                it                may have at law or in equity, terminate this Agreement by sending                notice                of termination in writing to the other party to such effect, and                such                termination shall be effective as of the date of the receipt of such                notice. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | This                Study and this Agreement may be terminated for any reason by the                Sponsor                or Sun Health Institute when in their independent and sole judgment                or                that of the Principal Investigator or the FDA, it is inappropriate,                impractical, or inadvisable to                continue. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | D. | Termination                of this Agreement by either party for any reason shall not affect                the                rights and obligations of the parties accrued prior to the effective                date                of termination of this Agreement. Upon termination of this Agreement                for                any reason except breach or default by Sun Health Institute Sponsor                shall                pay Sun Health Institute for all work performed through the effective                termination date, and all uncancelled obligations. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | E. | Sections                9, 10, 11, 12, 13, 14 and 15 of this Agreement shall survive expiration                or                termination of this Agreement. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 16. | Notices. |
|-----|----------|

|  | A. | In                carrying out this Agreement the parties shall comply with all local,                state                and federal laws and regulations. |
|--|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | B. | If                    any provision of this Agreement is determined to be invalid or                    void, the                          remaining provisions shall remain in                    effect. |
|--|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | This                Agreement (and the annexed Appendices) constitute the entire Agreement                between the parties and no variation, modification or waiver of any                of the                terms or conditions hereof shall be deemed valid unless made in writing                and signed by both parties hereto. This Agreement supersedes any                and all                prior agreements or understandings, whether oral or written, between                Sponsor and Sun Health Institute. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | D. | No                waiver by either party of any non-performance or violation by the                other                party of any of the covenants, obligations or agreements of such                other                party hereunder shall be deemed to be a waiver of any subsequent                violation                or non-performance of the same or any other covenant, agreement or                obligation, nor shall forbearance by any party be deemed to be a                waiver by                such party of its rights or remedies with respect to such violation                or                non-performance. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | F. | The                descriptive headings contained in this Agreement are included for                convenience and reference only and shall not be held to expand, modify                or                aid in the interpretation, construction or meaning of this                Agreement. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | G. | It                    is not the intent of the parties to create a partnership or joint                    venture                    or to       assume partnership                    responsibility or liability. The obligations of the parties shall                    be limited                    to those set out herein and such obligations shall be several                    and not                    joint. |
|--|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | H. | Sun                Health Institute and Investigator each represents and warrants to                Sponsor                that it has not been “debarred” by the United States Food & Drug                Administration (“FDA”), nor have debarment proceedings against it been                commenced. Sun Health Institute and Investigator will immediately                notify                Sponsor in writing if any such proceedings have commenced or if Sun                Health                Institute and/or Investigator are debarred by the                FDA. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| BY:                  SPONSOR/Power3 Medical Products, Inc. | BY:                  Sun Health Institute |
|------------------------------------------------------------|-------------------------------------------|
|                                                       |                                      |
|                                                       |                                      |
| s://Steven                  B. Rash                        | s://John                  L. Roach        |
| Steven                  B. Rash                            | Name:                  John L Roach       |
| Chief                  Executive Officer Title: CFO        |                                      |
|                                                       |                                      |
| Date:                  11/6/07                             | Date:                  12/4/07            |

----

**BC0001      **
** **
**“Studying      serum protein profile from patient’s with disease’s vs. age-matched control& disease-like disorder’s **

----

----